Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Delaware Health News Online.
Press releases published on August 7, 2025
89bio Reports Second Quarter 2025 Financial Results and Corporate Updates
GlobeNewswire
·
August 7, 2025
– ENLIGHTEN-Fibrosis and ENLIGHTEN-Cirrhosis Phase 3 topline histology data expected in 1H 2027 and in 2028, respectively; each trial designed to support accelerated approval to treat patients with metabolic dysfunction-associated steatohepatitis (MASH) – …
Apyx Medical Expands Global Sales Leadership with Strategic Hires to Support AYON Launch and Accelerated Growth
GlobeNewswire
·
August 7, 2025
CLEARWATER, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation, an advanced energy technology company and manufacturer of Renuvion® and the newly launched AYON Body Contouring System™, today announced the strategic appointments of two …
Organogenesis Holdings Inc. Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 7, 2025
CANTON, Mass., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and …
Relmada Therapeutics Reports Second Quarter 2025 Financial Results and Announces NDV-01 6-Month Follow-up Safety and Efficacy Data in NMIBC
GlobeNewswire
·
August 7, 2025
6-month follow-up for NDV-01 showed a 91% overall response rate at any time in non-muscle invasive bladder cancer, with good overall safety Enrollment in the Phase 2 study for NDV-01 continues, with updates expected at 9 and 12 month data follow-up. …
Sight Sciences Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Revenue Guidance
GlobeNewswire
·
August 7, 2025
MENLO PARK, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform …
Fractyl Health Announces Closing of $23 Million Underwritten Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional Shares
GlobeNewswire
·
August 7, 2025
Offering included participation from leading institutional investors, including Nantahala Capital, ADAR1 Capital Management, Second Line Capital, 683 Capital, and SilverArc Capital Proceeds expected to extend cash runway through key upcoming 3-and 6-month …
Scientific Industries Completes Strategic Refocus and Secures Proceeds of $10 million to Accelerate Growth of Two Data-Driven Business Platforms; Divests Genie® Division to OHAUS Corporation’s affiliate Troemner, LLC
GlobeNewswire
·
August 7, 2025
Realign priorities - AI-powered platforms to accelerate innovation and market leadership Driving transformation in pharmacy automation with VIVID’s advanced solutions Advancing AI-powered biomanufacturing with SBI’s DOTS Platform BOHEMIA, N.Y., Aug. 07, …
Interpace Biosciences Announces Second Quarter 2025 Financial and Business Results
GlobeNewswire
·
August 7, 2025
● Q2 Revenue of $9.2 million ● Q2 Cash Collections of $10.8 million ● Q2 Thyroid test volume up 16% year-over-year to record levels ● Q2 Thyroid revenue of $8.7M; up 25% year-over-year to record levels PARSIPPANY, NJ, Aug. 07, 2025 (GLOBE NEWSWIRE) …
The Joint Corp. Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 7, 2025
- Refranchised 37 clinics; Franchises now represent 92% of the portfolio - - Acquired rights to the Northwest regional developer territory - SCOTTSDALE, Ariz., Aug. 07, 2025 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager, …
Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 7, 2025
Phase 2b NAVIGATE clinical trial evaluating CD388 for the prevention of seasonal influenza met primary and all secondary efficacy endpoints for all dose groups End of Phase 2 meeting request submitted to the U.S. Food and Drug Administration (FDA) Closed …
IMAC Holdings Announces Research Collaboration with Vanderbilt University Medical Center to Advance Immuno-Oncology Biomarker Discovery
GlobeNewswire
·
August 7, 2025
Project will leverage Ignite Proteomics’ reverse-phase protein array (RPPA) platform to profile tumor-immune signaling in breast-cancer samples Golden, CO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Ignite Proteomics LLC, a subsidiary of IMAC Holdings, Inc. (OTCQB: …
Omada Health Reports Second Quarter 2025 Results
GlobeNewswire
·
August 7, 2025
Revenue of $61 million, up 49% 52% Member Growth and Significant Progress Toward Profitability SAN FRANCISCO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Omada Health, Inc. (Nasdaq: OMDA), the virtual between-visit healthcare provider, today reported financial …
Health Catalyst Reports Second Quarter 2025 Results
GlobeNewswire
·
August 7, 2025
SALT LAKE CITY, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended …
Progyny, Inc. Announces Second Quarter 2025 Results
GlobeNewswire
·
August 7, 2025
Reports Record Revenue of $332.9 Million, Reflecting 9.5% Growth Generates $55.5 Million in Quarterly Operating Cash Flow and Record $105.3 Million over the First Half of 2025 Raises Full Year Guidance to Reflect Continued Increase in Pacing of Member …
scPharmaceuticals Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 7, 2025
Generated net FUROSCIX® revenue of $16 million in the second quarter of 2025; up 99% over Q2 2024 Doses shipped to patients increased 45% over Q1 2025 and 117% over Q2 2024 Launch of FUROSCIX in chronic kidney disease Autoinjector remains on track for sNDA …
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2025
GlobeNewswire
·
August 7, 2025
$60.0M in 2Q25 Total Product Revenue More than 100 Patients Treated with Amtagvi® in 2Q25 Strategic Restructuring Extends Cash Runway into 4Q26 FY25 Total Product Revenue Guidance of $250M-$300M Reiterated SAN CARLOS, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) …
ThreeSixty Journalism Concludes 2025 Storytelling Institute for Local Students
GlobeNewswire
·
August 7, 2025
ST. PAUL, Minn., Aug. 07, 2025 (GLOBE NEWSWIRE) -- ThreeSixty Journalism has successfully concluded its 2025 Multimedia Storytelling Institute, a three-week summer camp held July 7 through July 24 at the University of St. Thomas College of Arts and …
Galapagos Creates New Subscription Right Plan
GlobeNewswire
·
August 7, 2025
Mechelen, Belgium; August 7, 2025, 22.01 CET; regulated information – Galapagos NV (Euronext …
Galapagos creëert nieuw inschrijvingsrechtenplan
GlobeNewswire
·
August 7, 2025
Mechelen, België; 7 augustus 2025, 22.01 CET; gereglementeerde informatie – Galapagos NV (Euronext …
Celldex Reports Second Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
August 7, 2025
Strong execution and continued progress across pipeline Unprecedented data delivered from Phase 2 CSU study demonstrating profound, sustained complete response and improved quality of life 7 months after completion of barzolvolimab dosing Data anticipated …